Are you aged 60 years or older? Help us find a way to prevent RSV disease.
Older adults are at an increased risk of developing serious complications, including inflammation of the lungs or pneumonia, from respiratory syncytial virus, or RSV. The main goal of the EVERGREEN Study is to see if an investigational study vaccine can prevent RSV disease caused by a respiratory syncytial virus in older adults.
You may be eligible to take part in the study if you are 60 years of age or older, can do your usual daily activities even with some interference from any health conditions, and are able to use smartphone, tablet or computer. Those who qualify may receive the investigational study vaccine and trial-related medical care at no cost and reimbursement for study-related travel expenses.
Participants may receive study-related care throughout the study from a team of experienced doctors and nurses, at our clinic in Stoke.
We're talking new year resolutions...
Tidying the house before going to bed each night, meditating upon waking or taking the stairs at work.
What’s something quick, or easy, that you started doing that made a major positive change in your life?
Share your summer photos! 📷
Taken some beautiful snaps lately? Whether it's rainbows, sunsets or a beautiful summer's day, we'd love you to share the joy with us.
Share a photo in the comments below